This study investigated the 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics
The study included 322 consecutive AAA patients treated electively with EVAR from March 2016 to February 2019 at a tertiary referral center. Early follow-up with clinical and laboratory evaluation took place at the 30rd day post-operatively. Any adverse event, such as major adverse cardiovascular events (MACE), post-implantation syndrome (PIS), acute kidney injury (AKI), and deaths of any cause were recorded.
Study Type
OBSERVATIONAL
Enrollment
322
The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed
University Hospital of Larissa
Larissa, Thessaly, Greece
Number of patients with major adverse cardiovascular events
Number of participants with major adverse cardiovascular events
Time frame: 30rd day post-operatively
Number of patients with acute kidney injury
Number of participants with acute kidney injury according to the RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria
Time frame: 30rd day post-operatively
Number of patients with post-implantation syndrome
Number of participants with post-implantation syndrome SIRS, without any apparent sign of infection
Time frame: 30rd day post-operatively
Deaths of any cause
Number of participants who died from any cause
Time frame: 30rd day post-operatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.